You just read:

Isis Pharmaceuticals Reports Data From Phase 2 Study of ISIS-PTP1B Rx in Patients With Type 2 Diabetes

News provided by

Isis Pharmaceuticals, Inc.

Feb 03, 2015, 07:00 ET